Ulf Landmesser

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895

2023 ESC Guidelines for the management of acute coronary syndromes

peer reviewed

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

peer reviewed

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

International audience

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

<p>Prepared by The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)</p> \n<p...

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

International audience

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

peer reviewed

2014 ESC/EACTS Guidelines on myocardial revascularization

peer reviewed

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Consistent evidence from numerous and multiple different types of clinical and genetic studies unequivocally establishes that LDL causes ASCVD.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias

peer reviewed

The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation